Sanne De Jongh is Partner (Life Sciences) at Oxford Science Enterprises, joining in 2023. She previously held investment roles at biotech venture funds Gilde Healthcare, Anterra Capital, and M Ventures. She earned a BSc in Biochemistry from Leiden University and an MSc in Biochemical Engineering from Delft University of Technology.
Education
BSc, Biochemistry, Leiden University
MSc, Biochemical Engineering, Delft University of Technology